NCT00862940View on ClinicalTrials.gov

A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

April 30, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

Memantine

10 mg tablets twice daily

DRUG

Placebo

Tablets twice daily

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00862940 - A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter